ADVAGEN
LIVE

Serial Number

98344686

Owner

Advagen Pte. Ltd.

Attorney

WILLIAM SCOTT GOLDMAN

Filing Date

Jan 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ADVAGEN Trademark

Serial Number: 98344686

ADVAGEN is a trademark filed by Advagen Pte. Ltd. on January 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Advagen Pte. Ltd. (3 trademarks)

73 Ubi Road 1 #08-52
Oxley Bizhub 408729 , SG

Entity Type: 99

Trademark Details

Filing Date

January 5, 2024

Registration Date

Not Registered

Published for Opposition

November 19, 2024

Goods & Services

Dietary Supplements; Nutritional Supplements; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Digestives for pharmaceutical purposes; Dextrins for pharmaceutical use; Starch for pharmaceutical purposes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the central nervous system; Plant extracts, other than essential oils, for pharmaceutical purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Therapeutic pharmaceutical for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; All aforementioned goods not for use in parenteral nutrition

Filing History

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 20, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Mar 19, 2025 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 19, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2024 NWOS
NEW APPLICATION ENTERED
Jan 5, 2024 NWAP